Kerrisdale Capital Management was founded by Hasn Adrangi in the year 2009. Since then, he has made sure to stay involved in each area of developing the firm. Although Kerrisdale is currently managing $150 million, Adgrangi started the company with only a little under $1 million.
In addition to his short selling results, Sahm Adrangi is also quite well-known for all the research that he has published over the years. He has never held back from sharing the firm’s views, and has spoken about both overyhyped shorts and under-followed longs. Adrangi believes that the market holds many misconceptions about the prospects of these companies, and he hopes to challenge and correct these notions by making Kerrisdale’s research available to the public.
During 2010 and 2011, Sahm Adrangi shorted several fraudulent Chinese companies, which he later exposed publicly. Lihua International, China Marine Food Group and China-Biotics are all examples of such companies. Thanks to him, the Securities and Exchange Commission eventually took enforcement actions against many of the companies that he exposed, including ChinaCast Education Corp and China Education Alliance.
More recently, he has shifted his focus primarily to the biotechnology sector, despite continuing to share research concerning a diverse range of businesses and sectors. Kerrisdale’s research takes particular interest in the development stage of these companies. Recently released research in the biotechnology sector has covered Bavarian Nordic, Zafgen, Sage Therapeutics and Unilife.
Sahm Adrangi earned his Bachelor of Arts in Economics upon graduating form Yale University. He was employed by Deutsche Bank at the start of his career in the world of finance. At one point he also spent many years at Longacre Management, a hedge fund managing several billion dollars.
Sahm Adrangi’s success has not gone unnoticed by the media. Several big players in the television and newspaper world have conducted interviews with him, and he has also shared some of his knowledge with other investors at various conferences.